Učitavanje...
The productivity limit of manufacturing blood cell therapy in scalable stirred bioreactors
Manufacture of red blood cells (RBCs) from progenitors has been proposed as a method to reduce reliance on donors. Such a process would need to be extremely efficient for economic viability given a relatively low value product and high (2 × 10(12)) cell dose. Therefore, the aim of these studies was...
Spremljeno u:
| Izdano u: | J Tissue Eng Regen Med |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5811890/ https://ncbi.nlm.nih.gov/pubmed/27696710 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/term.2337 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|